The Food and Drug Administration (FDA) told the maker of Purell to discontinue marketing campaigns that includes claims for avoiding flu and ebola, according to an article on The New York Times website.
The campaigns also claim the product can prevent spread of MRSA and norovirus.
The FDA told Gojo Industries that its claims that Purell could reduce the potential for infection or prevent illnesses violated the Federal Food, Drug and Cosmetic Act.
The agency said it was reclassifying Purell as an unapproved drug, rather than an over-the-counter product.
Parking: Where the Outpatient Land Crunch Shows First
Clear Behavioral Health Opens New Outpatient Mental Health Center in Anaheim Hills
Bon Secours Begins Construction on Freestanding Emergency Department in Norfolk
The OR HVAC Puzzle: Why Individual Systems Are on the Rise
Skanska Completes Renovation of Specialized Care Facility for Sutter Health